PURA VIDA INVESTMENTS, LLC
Filing Date
Global Rank
#7,566
/ 8,232
▼ 159
Top Industry
Medical Devices
44.2%
3Y Alpha vs SPY
-35.2%
Period ended 2 months ago
Filed May 12, 2026 · 33d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-37.2%
SPY
+76.3%
Annualised alpha
-35.2%
Max drawdown
−59.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
16 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
21.4%
−11.5 pts
Top 5
74.4%
−10.6 pts
Top 10
88.6%
−5.8 pts
HHI
1,352
Diversified−745
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 82.5% | $11,996,549 |
| Technology | 11.5% | $1,667,230 |
| Financial Services | 2.7% | $397,116 |
| Basic Materials | 1.7% | $247,880 |
| Consumer Cyclical | 1.6% | $229,097 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MSFT | Microsoft Corp | −210 | 990 | $366,468 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| DHR | Danaher Corp /De/ | 900 | $206,028 | |
| No positions match the current search. | ||||
16 positions ·
$14,537,872 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| IMDX |
Insight Molecular Diagnostics Inc.
Healthcare
|
Held | 947,134 | $3,106,599 | 21.37% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
Held | 281,250 | $2,818,125 | 19.38% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
Held | 45,000 | $2,555,100 | 17.58% | |
| CAI |
Caris Life Sciences, Inc.
Healthcare
|
Held | 89,940 | $1,608,127 | 11.06% | |
| NSPR |
InspireMD, Inc.
Healthcare
|
Held | 450,517 | $734,342 | 5.05% | |
| NTRA |
Natera, Inc.
Healthcare
|
Held | 2,500 | $499,975 | 3.44% | |
| NVDA |
Nvidia Corp
Technology
|
Added | 2,500 | $436,000 | 3.00% | |
| JPM |
Jpmorgan Chase & Co
Financial Services
|
Held | 1,350 | $397,116 | 2.73% | |
| MSFT |
Microsoft Corp
Technology
|
Reduced | 990 | $366,468 | 2.52% | |
| MGX |
Metagenomi Therapeutics, Inc.
Healthcare
|
Held | 264,391 | $354,283 | 2.44% | |
| OM |
Outset Medical, Inc.
Healthcare
|
Added | 83,333 | $319,998 | 2.20% | |
| ADI |
Analog Devices Inc
Technology
|
Held | 1,000 | $318,140 | 2.19% | |
| AAPL |
Apple Inc.
Technology
|
Held | 1,165 | $295,665 | 2.03% | |
| ASML |
Asml Holding NV
Technology
|
Held | 190 | $250,957 | 1.73% | |
| LIN |
Linde PLC
Basic Materials
|
Held | 500 | $247,880 | 1.71% | |
| AMZN |
Amazon Com Inc
Consumer Cyclical
|
Added | 1,100 | $229,097 | 1.58% |